Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 Tat protein (Trans-Activator of Transcription) is a small, regulatory viral protein essential for efficient transcription and replication of the HIV-1 genome. It binds to the TAR RNA element and recruits host cellular factors to enhance transcriptional elongation. Tat also modulates cellular gene expression, alters immune responses, and facilitates viral spread. It is considered a potential therapeutic target.
Enhances transcriptional elongation from the integrated HIV provirus by binding to the TAR RNA element and recruiting P-TEFb.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Tat protein (None).